cmv Antibody
cmv Antibody
) CMV Control lentiviral particles (Bsd) |
|||
| CMV-Null-Bsd | GenTarget | 1 x107 IFU/ml x 200ul | 418.8 EUR |
|
Description: Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the blasticidin marker under RSV promoter. |
|||
) CMV Control lentiviral particles (Neo) |
|||
| CMV-Null-Neo | GenTarget | 1 x107 IFU/ml x 200ul | 418.8 EUR |
|
Description: Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the Neomycin marker under RSV promoter. |
|||
) CMV Control lentiviral particles (Puro) |
|||
| CMV-Null-Puro | GenTarget | 1 x107 IFU/ml x 200ul | 418.8 EUR |
|
Description: Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the Puromycin marker under RSV promoter. |
|||
) CMV Control lentiviral particles (GFP-Bsd) |
|||
| CMV-Null-GB | GenTarget | 1 x107 IFU/ml x 200ul | 418.8 EUR |
|
Description: Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the GFP-Blasticidin fusion marker under RSV promoter. |
|||
) CMV Control lentiviral particles (GFP-Puro) |
|||
| CMV-Null-GP | GenTarget | 1 x107 IFU/ml x 200ul | 418.8 EUR |
|
Description: Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the GFP-Puromycin fusion marker under RSV promoter. |
|||
) CMV Control lentiviral particles (RFP-Bsd) |
|||
| CMV-Null-RB | GenTarget | 1 x107 IFU/ml x 200ul | 418.8 EUR |
|
Description: Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the RFP-Blasticidin fusion marker under RSV promoter. |
|||
) CMV Control lentiviral particles (RFP-Puro) |
|||
| CMV-Null-RP | GenTarget | 1 x107 IFU/ml x 200ul | 418.8 EUR |
|
Description: Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the RFP-Puromycin fusion marker under RSV promoter. |
|||
 in PBS) CMV Control lentiviral particles (Bsd) in PBS |
|||
| CMV-Null-Bsd-PBS | GenTarget | 1 x108 IFU/ml x 200ul | 852 EUR |
|
Description: Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the blasticidin marker under RSV promoter. The virus was concentrated and provided in PBS solution. |
|||
 in PBS) CMV Control lentiviral particles (Neo) in PBS |
|||
| CMV-Null-Neo-PBS | GenTarget | 1 x108 IFU/ml x 200ul | 852 EUR |
|
Description: Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the Neomycin marker under RSV promoter. The virus was concentrated and provided in PBS solution. |
|||
 in PBS) CMV Control lentiviral particles (Puro) in PBS |
|||
| CMV-Null-Puro-PBS | GenTarget | 1 x108 IFU/ml x 200ul | 852 EUR |
|
Description: Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the Puromycin marker under RSV promoter. The virus was concentrated and provided in PBS solution. |
|||
 in PBS) CMV Control lentiviral particles (GFP-Bsd) in PBS |
|||
| CMV-Null-GB-PBS | GenTarget | 1 x108 IFU/ml x 200ul | 852 EUR |
|
Description: Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the GFP-Blasticidin fusion marker under RSV promoter. The virus was concentrated and provided in PBS solution. |
|||
 in PBS) CMV Control lentiviral particles (GFP-Puro) in PBS |
|||
| CMV-Null-GP-PBS | GenTarget | 1 x108 IFU/ml x 200ul | 852 EUR |
|
Description: Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the GFP-Puromycin fusion marker under RSV promoter. The virus was concentrated and provided in PBS solution. |
|||
 in PBS) CMV Control lentiviral particles (RFP-Bsd) in PBS |
|||
| CMV-Null-RB-PBS | GenTarget | 1 x108 IFU/ml x 200ul | 852 EUR |
|
Description: Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the RFP-Blasticidin fusion marker under RSV promoter. The virus was concentrated and provided in PBS solution. |
|||
 in PBS) CMV Control lentiviral particles (RFP-Puro) in PBS |
|||
| CMV-Null-RP-PBS | GenTarget | 1 x108 IFU/ml x 200ul | 852 EUR |
|
Description: Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the RFP-Puromycin fusion marker under RSV promoter. The virus was concentrated and provided in PBS solution. |
|||
 CMV antibody |
|||
| 10-1439 | Fitzgerald | 200 ug | 830.4 EUR |
|
Description: Mouse monoclonal CMV antibody |
|||
CMV antibody |
|||
| 10-C50C | Fitzgerald | 200 ug | 830.4 EUR |
|
Description: Mouse monoclonal CMV antibody |
|||
CMV antibody |
|||
| 10-C50D | Fitzgerald | 200 ug | 830.4 EUR |
|
Description: Mouse monoclonal CMV antibody |
|||
CMV antibody |
|||
| 10-C50F | Fitzgerald | 200 ug | 830.4 EUR |
|
Description: Mouse monoclonal CMV antibody |
|||
CMV antibody |
|||
| 10-C50G | Fitzgerald | 200 ug | 830.4 EUR |
|
Description: Mouse monoclonal CMV antibody |
|||
CMV antibody |
|||
| 10-C50L | Fitzgerald | 1 mg | 165.6 EUR |
|
Description: Mouse monoclonal CMV antibody |
|||
CMV antibody |
|||
| 10-C50M | Fitzgerald | 1 mg | 159.6 EUR |
|
Description: Mouse monoclonal CMV antibody |
|||
CMV antibody |
|||
| 10-C50N | Fitzgerald | 1 mg | 159.6 EUR |
|
Description: Mouse monoclonal CMV antibody |
|||
CMV antibody |
|||
| 10-C50P | Fitzgerald | 200 ug | 878.4 EUR |
|
Description: Mouse monoclonal CMV antibody |
|||
CMV antibody |
|||
| 10-C50R | Fitzgerald | 200 ug | 289.2 EUR |
|
Description: Mouse monoclonal CMV antibody |
|||
CMV antibody |
|||
| 20-CG70 | Fitzgerald | 1 mg | 139.2 EUR |
|
Description: Goat polyclonal CMV antibody |
|||
CMV antibody |
|||
| 10C-CR1294M1 | Fitzgerald | 100 ug | 429.6 EUR |
|
Description: Mouse monoclonal CMV antibody |
|||
CMV antibody |
|||
| 10C-CR2126M1 | Fitzgerald | 200 ug | 748.8 EUR |
|
Description: Mouse monoclonal CMV antibody |
|||
CMV antibody |
|||
| 10R-C180a | Fitzgerald | 1 mg | 536.4 EUR |
|
Description: Mouse monoclonal CMV antibody |
|||
 CMV Antibody |
|||
| abx021636-1mg | Abbexa | 1 mg | 718.8 EUR |
CMV Antibody |
|||
| abx021637-1mg | Abbexa | 1 mg | 1646.4 EUR |
CMV Antibody |
|||
| abx021638-1mg | Abbexa | 1 mg | 1446 EUR |
CMV Antibody |
|||
| abx021639-1mg | Abbexa | 1 mg | 2798.4 EUR |
CMV Antibody |
|||
| abx021640-100ug | Abbexa | 100 ug | 794.4 EUR |
CMV Antibody |
|||
| abx021641-1mg | Abbexa | 1 mg | 1880.4 EUR |
CMV Antibody |
|||
| abx021642-100ug | Abbexa | 100 ug | 710.4 EUR |
CMV Antibody |
|||
| abx021643-100ug | Abbexa | 100 ug | 794.4 EUR |
CMV Antibody |
|||
| abx022961-1ml | Abbexa | 1 ml | 878.4 EUR |
) CMV antibody (FITC) |
|||
| 60-C69 | Fitzgerald | 1 ml | 403.2 EUR |
|
Description: Goat polyclonal CMV antibody (FITC) conjugated |
|||
) CMV antibody (HRP) |
|||
| 60-C70 | Fitzgerald | 1 ml | 480 EUR |
|
Description: Goat polyclonal CMV antibody (HRP) conjugated |
|||
) CMV antibody (biotin) |
|||
| 60C-CR2126GB | Fitzgerald | 1 ml | 435.6 EUR |
|
Description: Goat polyclonal CMV antibody (biotin) conjugated |
|||
 CMV ICP36 antibody |
|||
| 10-C50I | Fitzgerald | 100 ug | 328.8 EUR |
|
Description: Mouse monoclonal CMV ICP36 antibody |
|||
 CMV pp65 antibody |
|||
| 10-C50K | Fitzgerald | 200 ug | 442.8 EUR |
|
Description: Mouse monoclonal CMV pp65 antibody |
|||
 CMV gB antibody |
|||
| 10R-H106a | Fitzgerald | 100 ug | 418.8 EUR |
|
Description: Mouse monoclonal CMV gB antibody |
|||
 Anti-CMV antibody |
|||
| STJ180079 | St John's Laboratory | 0.1 ml | 254.4 EUR |
 CMV p28 UL99 antibody |
|||
| 10-C50J | Fitzgerald | 200 ug | 327.6 EUR |
|
Description: Mouse monoclonal CMV p28 UL99 antibody |
|||
 Antibody) CMV-p65(CMV100) Antibody |
|||
| BNC040100-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against CMV-p65(CMV100), CF405S conjugate, Concentration: 0.1mg/mL |
|||
CMV-p65(CMV100) Antibody |
|||
| BNC040100-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against CMV-p65(CMV100), CF405S conjugate, Concentration: 0.1mg/mL |
|||
 Antibody) CMV-p65(CMV101) Antibody |
|||
| BNC040101-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against CMV-p65(CMV101), CF405S conjugate, Concentration: 0.1mg/mL |
|||
CMV-p65(CMV101) Antibody |
|||
| BNC040101-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against CMV-p65(CMV101), CF405S conjugate, Concentration: 0.1mg/mL |
|||
CMV-p65(CMV100) Antibody |
|||
| BNC050100-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against CMV-p65(CMV100), CF405M conjugate, Concentration: 0.1mg/mL |
|||
CMV-p65(CMV100) Antibody |
|||
| BNC050100-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against CMV-p65(CMV100), CF405M conjugate, Concentration: 0.1mg/mL |
|||
CMV-p65(CMV101) Antibody |
|||
| BNC050101-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against CMV-p65(CMV101), CF405M conjugate, Concentration: 0.1mg/mL |
|||
CMV-p65(CMV101) Antibody |
|||
| BNC050101-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against CMV-p65(CMV101), CF405M conjugate, Concentration: 0.1mg/mL |
|||
CMV-p65(CMV100) Antibody |
|||
| BNCAP0100-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against CMV-p65(CMV100), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
CMV-p65(CMV100) Antibody |
|||
| BNCAP0100-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against CMV-p65(CMV100), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
CMV-p65(CMV101) Antibody |
|||
| BNCAP0101-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against CMV-p65(CMV101), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
CMV-p65(CMV101) Antibody |
|||
| BNCAP0101-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against CMV-p65(CMV101), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
CMV-p65(CMV100) Antibody |
|||
| BNCB0100-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against CMV-p65(CMV100), Biotin conjugate, Concentration: 0.1mg/mL |
|||
CMV-p65(CMV100) Antibody |
|||
| BNCB0100-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against CMV-p65(CMV100), Biotin conjugate, Concentration: 0.1mg/mL |
|||
CMV-p65(CMV101) Antibody |
|||
| BNCB0101-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against CMV-p65(CMV101), Biotin conjugate, Concentration: 0.1mg/mL |
|||
CMV-p65(CMV101) Antibody |
|||
| BNCB0101-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against CMV-p65(CMV101), Biotin conjugate, Concentration: 0.1mg/mL |
|||
CMV-p65(CMV100) Antibody |
|||
| BNCP0100-250 | Biotium | 250uL | 459.6 EUR |
|
Description: Primary antibody against CMV-p65(CMV100), PerCP conjugate, Concentration: 0.1mg/mL |
|||
CMV-p65(CMV101) Antibody |
|||
| BNCP0101-250 | Biotium | 250uL | 459.6 EUR |
|
Description: Primary antibody against CMV-p65(CMV101), PerCP conjugate, Concentration: 0.1mg/mL |
|||
CMV-p65(CMV100) Antibody |
|||
| BNCR0100-250 | Biotium | 250uL | 459.6 EUR |
|
Description: Primary antibody against CMV-p65(CMV100), RPE conjugate, Concentration: 0.1mg/mL |
|||
CMV-p65(CMV101) Antibody |
|||
| BNCR0101-250 | Biotium | 250uL | 459.6 EUR |
|
Description: Primary antibody against CMV-p65(CMV101), RPE conjugate, Concentration: 0.1mg/mL |
|||
CMV-p65(CMV100) Antibody |
|||
| BNC940100-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against CMV-p65(CMV100), CF594 conjugate, Concentration: 0.1mg/mL |
|||
CMV-p65(CMV100) Antibody |
|||
| BNC940100-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against CMV-p65(CMV100), CF594 conjugate, Concentration: 0.1mg/mL |
|||
CMV-p65(CMV101) Antibody |
|||
| BNC940101-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against CMV-p65(CMV101), CF594 conjugate, Concentration: 0.1mg/mL |
|||
CMV-p65(CMV101) Antibody |
|||
| BNC940101-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against CMV-p65(CMV101), CF594 conjugate, Concentration: 0.1mg/mL |
|||
CMV-p65(CMV100) Antibody |
|||
| BNCA0100-250 | Biotium | 250uL | 459.6 EUR |
|
Description: Primary antibody against CMV-p65(CMV100), APC conjugate, Concentration: 0.1mg/mL |
|||
CMV-p65(CMV101) Antibody |
|||
| BNCA0101-250 | Biotium | 250uL | 459.6 EUR |
|
Description: Primary antibody against CMV-p65(CMV101), APC conjugate, Concentration: 0.1mg/mL |
|||
CMV-p65(CMV100) Antibody |
|||
| BNC810100-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against CMV-p65(CMV100), CF680R conjugate, Concentration: 0.1mg/mL |
|||